Oral Care is a leading dental care provider in Sweden, Norway and the Netherlands, operating a growing network of high-quality dental clinics. Since Axcel’s investment in 2022, the group has grown through a combination of organic growth and acquisitions, with the acquisition of DTG marking a major milestone. Together, the two providers will operate some 80 clinics, forming a unified group with a strong foundation for further expansion.

“We are thrilled to welcome De Tandartsengroep to Oral Care”, says Martin Sellman, CEO of Oral Care. “This partnership reinforces our commitment to delivering exceptional dental care to our patients while fostering an outstanding work environment where dental professionals can thrive.”

DTG operates 31 clinics and eight dental labs in the Netherlands, with a well-established presence in the highly fragmented and steadily growing Dutch dental care market. The combination of Oral Care and DTG creates a unique cross-border platform with a diversified service offering and a proven track record of growth through partnerships with high-quality dental clinics.

“This partnership aligns seamlessly with the reason why De Tandartsengroep was founded seven years ago,” says Jakko Vinken, CEO of DTG. “Both organisations believe in a decentralised model, allowing dentists to make decisions in the best interest of their patients. Dentists will benefit from shared resources and ongoing investments in equipment, innovation, education and administration, ensuring the best possible care for our patients.”

A commitment to building market leaders
In connection with the acquisition of DTG, Axcel VII will invest in Oral Care alongside Axcel VI, providing financial flexibility to continue the group’s acquisition strategy and strengthen its market position.

“This investment is a testament to Axcel’s commitment to building market leaders,” says Thomas Blomqvist, Partner at Axcel. “Oral Care has already established itself as a high-quality operator, and with DTG on board we see a compelling opportunity to create a leading multi-country dental group. We’re excited to support this next phase of growth for Oral Care.”

Oral Care’s successful growth strategy has positioned it as one of the fastest-growing dental care chains in Northern Europe. The group’s strong reputation, focus on high-quality dental care and proven ability to integrate acquired clinics make it a prime platform for further growth in existing markets and beyond.

The investment in Oral Care, alongside Axcel VI’s existing investment in the group, marks the seventh investment for Axcel VII. The transaction is subject to customary regulatory approvals, and closing is expected in the second quarter of 2025.